florencegenet

13th of November, 2025 - Uppsala, Sweden PeptiSystems, a life science company developing advanced manufacturing solutions for peptide and oligonucleotide-based therapeutics, has announced a significant growth investment from Rubicon Healthcare Partners. The partnership will enable PeptiSystems to accelerate its global expansion and deliver scalable, next-generation manufacturing solutions to a rapidly growing biopharma market. Rubicon Healthcare Partners is a growth-oriented investment firm...

Uppsala, Sweden – 30 October 2025 PeptiSystems is continuing to grow its international footprint with new customer relationships in India. Two leading pharmaceutical organizations—Neuland Laboratories and Laurus Labs—have recently joined PeptiSystems’ expanding customer network in the region. Neuland Laboratories , a global Contract Development and Manufacturing Organization (CDMO), provides customized small-molecule and peptide development services to pharmaceutical and biotech companies...

Uppsala, Sweden – 30 September 2025 PeptiSystems has delivered an OligoNavigator synthesizer to Servier, marking an important milestone as the global pharmaceutical group takes its first step into in-house oligonucleotide synthesis. Servier  is an independent global pharmaceutical group headquartered in France, focused on research and development in oncology, cardiometabolism, neuroscience, and immuno-inflammatory diseases. The company has broadened its research to include new therapeutic...